Research Topics
| Alberto BroniscerSummaryAffiliation: St. Jude Children's Research Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420Alberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Clin Cancer Res 13:1511-5. 2007..To report cerebrospinal fluid (CSF) penetration of erlotinib and its metabolite OSI-420...
Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium reportAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA
Clin Cancer Res 13:6712-8. 2007..To estimate the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of escalating doses of temozolomide combined with O(6)-benzylguanine in patients < or =21 years with recurrent brain tumors...
Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine gliomaAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, and Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38105, USA
Cancer 116:4632-7. 2010..A prospective, multicenter study was conducted to assess the feasibility of tissue collection at autopsy and its suitability for molecular analyses in children with diffuse intrinsic pontine glioma...
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade gliomaAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Mail Stop 260, 262 Danny Thomas Place, Memphis, TN 38105, USA
Clin Cancer Res 15:701-7. 2009....
Clinical and molecular characteristics of malignant transformation of low-grade glioma in childrenAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 25:682-9. 2007..To analyze the clinical and molecular characteristics of malignant transformation (MT) of low-grade glioma (LGG) in children...
Young age may predict a better outcome for children with diffuse pontine gliomaAlberto Broniscer
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 113:566-72. 2008..Because diffuse pontine glioma (DPG) is rare among young children, the outcome of affected patients is unknown...
Past, present, and future strategies in the treatment of high-grade glioma in childrenAlberto Broniscer
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cancer Invest 24:77-81. 2006..Despite the use of multimodality therapy, less than 20 percent of these children are long-term survivors. This review provides an overview of relevant past, current and future treatment strategies for high-grade glioma in children...
Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem gliomaAlberto Broniscer
Department of Hematology Oncology, St Jude Children s Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA
Cancer 106:1364-71. 2006..In the current study, the authors assessed the characteristics and estimated the cumulative incidence of IH among children with BSG...
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in childrenAlberto Broniscer
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
J Neurooncol 76:313-9. 2006..Although the heterogeneity of prognostic factors in our patients made assessment of treatment outcome more difficult, the addition of 6 cycles of temozolomide after radiotherapy did not seem to alter the poor outcome of these patients...
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98)Alberto Broniscer
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 103:133-9. 2005..The role of chemotherapy in the treatment of children with newly diagnosed diffuse brainstem glioma is uncertain. In the current study, the authors tested the efficacy of temozolomide treatment after radiotherapy (RT) in this setting...
Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experienceAlberto Broniscer
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 100:2246-52. 2004..Details on second neoplasms (SNs) following pediatric central nervous system (CNS) tumors are scant, because of the rarity of such SNs. The goal of the current study was to investigate and characterize these rare SNs...
Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologistAlberto Broniscer
Division of Neuro Oncology, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Oncologist 9:197-206. 2004..Because the outcome for patients with either type of tumor is poor when standard multimodality therapy is used, these children are ideal candidates for innovative treatment approaches...
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine gliomaAlberto Broniscer
St Jude Children s Research Hospital, Memphis, TN, USA
J Clin Oncol 28:4762-8. 2010....
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastomaMaryam Fouladi
Department of Oncology, St Jude Children s Research Hospital, 332 North Lauderdale, Memphis, TN 38105 2794, USA
J Clin Oncol 26:3749-55. 2008....
Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastomaShawna L Palmer
Department of Behavioral Medicine, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Neuro Oncol 12:1311-7. 2010..This study highlights the need for careful follow-up with neuropsychological evaluation and for obtaining critical support for patients and their families...
Survival and late mortality in long-term survivors of pediatric CNS tumorsE Brannon Morris
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 25:1532-8. 2007..To describe the pattern of survival and late mortality among contemporary long-term survivors of pediatric CNS tumor...
Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous systemAtmaram S Pai Panandiker
Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN, USA
Int J Radiat Oncol Biol Phys 82:1756-63. 2012..To assess the pattern of treatment failure associated with current therapeutic paradigms for childhood atypical teratoid rhabdoid tumors (AT/RT)...
High-grade astrocytoma in very young childrenRobert P Sanders
Division of Neuro Oncology, Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 49:888-93. 2007..High-grade astrocytomas are rare in young children, but have been reported to have a better prognosis than similar tumors in older patients...
Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trialStephen J Laughton
Division of Neuro Oncology, Department of Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 26:1112-8. 2008....
Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experienceMark Van Poppel
Division of Pediatric Neurosurgery, University of Tennessee College of Medicine, Memphis, Tennessee, USA
J Neurosurg Pediatr 8:251-6. 2011....
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Lancet Oncol 7:813-20. 2006..We aimed to investigate the effectiveness of risk-adapted radiotherapy followed by a shortened period of dose-intense chemotherapy in children with medulloblastoma...
White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumorShawna L Palmer
Department of Psychology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Neuro Oncol 14:1185-93. 2012..Neuroprotective strategies are needed to preserve critical functions...
M1 Medulloblastoma: high risk at any ageRobert P Sanders
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
J Neurooncol 90:351-5. 2008..The prognosis for children with M1 medulloblastoma (positive CSF cytology) has not been well-defined...
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine gliomaBarbara S Paugh
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 29:3999-4006. 2011..We evaluated a large cohort of DIPGs to identify recurrent genomic abnormalities and gene expression signatures underlying DIPG...
Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brainLionel M L Chow
Department of Developmental Neurobiology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Cancer Cell 19:305-16. 2011..Gene expression profiling revealed striking similarities to subclasses of human diffuse astrocytoma. Astrocytomas were found within and outside of proliferative niches in the adult brain...
Phase I study of everolimus in pediatric patients with refractory solid tumorsMaryam Fouladi
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
J Clin Oncol 25:4806-12. 2007....
Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imagingChiaho Hua
Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, TN, USA
Int J Radiat Oncol Biol Phys 82:2047-54. 2012..To characterize therapy-induced changes in normal-appearing brainstems of childhood brain tumor patients by serial diffusion tensor imaging (DTI)...
Diagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumorsIbrahim Qaddoumi
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
Childs Nerv Syst 28:1017-24. 2012....
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapyTanya M Tekautz
Department of Hematology-Oncology, Mail Stop 260, St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105, USA
J Clin Oncol 23:1491-9. 2005..ATRT presenting in older patients can be cured using a combination of radiation and high-dose alkylating therapy. Older patients with relapsed ATRT can have salvage treatment using ICE chemotherapy...
Pharmacokinetics of erlotinib for the treatment of high-grade glioma in a pediatric patient with cystic fibrosis: case report and review of the literatureShannon R Christiansen
Department of Pharmaceutical Services, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pharmacotherapy 29:858-66. 2009....
Determination of vandetanib in human plasma and cerebrospinal fluid by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)Feng Bai
Department of Pharmaceutical Sciences, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Chromatogr B Analyt Technol Biomed Life Sci 879:2561-6. 2011..98, %CV ≤ 4.97, n=6). This method was successfully applied to the analysis of pharmacokinetic samples from children with brain tumors treated with oral vandetanib...
Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine gliomaUlrike Löbel
Department of Radiological Sciences, St Jude Children s Research Hospital, 262 Danny Thomas Place, Mail Stop 220, Memphis, TN 38105, USA
Neuroradiology 52:1167-77. 2010....
Characterization, treatment, and outcome of intracranial neoplasms in the first 120 days of lifeIbrahim Qaddoumi
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 3678, USA
J Child Neurol 26:988-94. 2011....
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasGang Wu
Department of Computational Biology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Nat Genet 44:251-3. 2012..3, or in the related HIST1H3B, encoding histone H3.1, that caused a p.Lys27Met amino acid substitution in each protein. An additional 14% of non-BS-PGs had somatic mutations in H3F3A causing a p.Gly34Arg alteration...
Dysembryoplastic neuroepithelial tumors and cognitive outcome: cure at a price?Ibrahim Qaddoumi
Division of Neuro Oncology, Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 116:5461-9. 2010..Dysembryoplastic neuroepithelial tumors (DNETs) are benign glioneuronal tumors that occur in children. These tumors are characterized by seizures, lack of neurologic deficits, and a seemingly benign course after resection...
Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tractsKathleen J Helton
Department of Radiological Sciences, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
J Neurosurg Pediatr 1:270-6. 2008..The authors sought to determine whether DT imaging and white matter tractography could detect axonal degeneration in patients with brainstem tumors...
Bone marrow transplantation for severe aplastic anemia secondary to temozolomideE Brannon Morris
Department of Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Neurooncol 91:237-9. 2009..We report the case of an adolescent patient with a high-grade glioma who, after >2 years of event-free survival, underwent successful bone marrow transplantation for treatment of temozolomide-induced severe aplastic anemia (SAA)...
Alexander disease: An important mimicker of focal brainstem gliomaKatherine Van Poppel
Division of Neurology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Pediatr Blood Cancer 53:1355-6. 2009..AD is a neurodegenerative disease which must be included in the differential for tumor-like lesions within the posterior fossa...
Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007Ching Hon Pui
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 30:2005-12. 2012..Treatment outcome for black patients with cancer has been significantly worse than for their white counterparts. We determined whether recent improved treatment had narrowed the gap in outcome between black and white pediatric patients...
Pediatric low-grade gliomas and the need for new options for therapy: Why and how?Ibrahim Qaddoumi
Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee, USA
Cancer Biol Ther 8:4-10. 2009..Such progress in pilocytic astrocytoma needs to be consolidated and expanded to other histologic varieties of pediatric low-grade gliomas...
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult diseaseBarbara S Paugh
St Jude Children s Research Hospital, Memphis, TN 38105, USA
J Clin Oncol 28:3061-8. 2010..To define copy number alterations and gene expression signatures underlying pediatric high-grade glioma (HGG)...
Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem gliomaDaphne A Haas-Kogan
University of California, San Francisco, San Francisco, CA, USA
Neuro Oncol 10:341-7. 2008..The MTD of tipifarnib with concurrent radiation is 125 mg/m(2)/dose b.i.d. One-year survival and progression-free survival estimates are 36.4% (SE 16.7%) and 9.4% (SE 6.3%), respectively...
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor ConsMark W Kieran
Dana Farber Cancer Institute and Children s Hospital Boston, Boston, MA 02115, USA
J Clin Oncol 25:3137-43. 2007..Primary objectives were to estimate the maximum-tolerated dose (MTD) and to describe the dose-limiting toxicities (DLTs) and pharmacokinetics of lonafarnib. Farnesylation inhibition of HDJ-2 in peripheral blood was also measured...
High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumorsAlberto Broniscer
Children's Cancer Group: New York University Medical Center, New York, NY, USA
Pediatr Blood Cancer 42:261-7. 2004..006 and 0.01, respectively). CONCLUSIONS: Patients with recurrent cortical PNETs can be cured with this strategy. Surgical debulking before, and irradiation after HDC play an important role in treatment success...
